

Chinese Journal of Pharmacovigilance ›› 2025, Vol. 22 ›› Issue (12): 1328-1333.
DOI: 10.19803/j.1672-8629.20250781
• Orginal Article • Previous Articles Next Articles
BAI Xue1, LI Jingcheng2, LI Xueli1*
Received:2025-11-05
Published:2025-12-19
CLC Number:
BAI Xue, LI Jingcheng, LI Xueli. Research Advances in Roles of Traditional Chinese Medicine in Improving Myocardial Infarction by Regulating Mitochondrial Homeostasis[J]. Chinese Journal of Pharmacovigilance, 2025, 22(12): 1328-1333.
| [1] ROTH GA, MENSAH GA, JOHSON CO, et al.Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study[J]. J Am Coll Cardiol, 2020, 76(25): 2982-3021. [2] WAl P, AZIZ N, SINGH YK, et al.Myocardial Infarction as a Consequence of Mitochondrial Dysfunction[J]. Curr Cardiol Rev, 2023(6): 23-30. [3] GE T, QI HF, YAO B, et al.Research Progress on Traditional Chinese Medicine for Treating Myocardial Ischemia Reperfusion Injury Through Targeted Regulation of Mitochondrial Quality Control System[J]. Chinese Traditional and Herbal Drugs(中草药), 2024, 55(15): 5331-5341. [4] CADETE VJJ, VASAM G, MENZIES KJ, et al.Mitochondrial Quality Control in the Cardiac System: an Integrative View[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(4): 782-796. [5] LUONGO TS, LAMBERT JP, GROSS P, et al.The Mitochondrial Na(+)/Ca(2+) Exchanger is Essential for Ca(2+) Homeostasis and Viability[J]. Nature, 2017, 545(7652): 93-97. [6] HALESTRAP AP, RICHARDSON AP.The Mitochondrial Permeability Transition: a Current Perspective on Its Identity and Role in Ischaemia/ Reperfusion Injury[J]. J Mol Cell Cardiol, 2015, 78: 129-141. [7] CHEN W, ZHAO H, LI Y.Mitochondrial Dynamics in Health and Disease: Mechanisms and Potential Targets[J]. Signal Transduct Target Ther, 2023, 8(1): 333. [8] AI OJAIMI M, SALAH A, EL-HATTAB AW.Mitochondrial Fission and Fusion: Molecular Mechanisms, Biological Functions, and Related Disorders[J]. Membranes (Basel), 2022, 12(9): 893. [9] LU Y, LI Z, ZHANG S, et al.Cellular Mitophagy: Mechanism, Roles in Diseases and Small Molecule Pharmacological Regulation[J]. Theranostics, 2023, 13(2): 736-766. [10] WANG S, LONG H, HOU L, et al.The Mitophagy Pathway and Its Implications in Human Diseases[J]. Signal Transduct Target Ther, 2023, 8(1): 304. [11] CHAANINE AH, JOYCE LD, STULAK JM, et al.Mitochondrial Morphology, Dynamics, and Function in Human Pressure Overload or Ischemic Heart Disease with Preserved or Reduced Ejection Fraction[J]. Circ Heart Fail, 2019, 12(2): e005131. [12] MA XG, ZHAO SC, LI SX.Effects of Red Ginseng Polysaccharide on Myocardial Fibrosis and Mitochondrial Energy Metabolism in Mice with Coronary Heart Disease[J]. Chinese Journal of Evidence-Based Cardiovascular Medicine(中国循证心血管医学杂志), 2023, 15(6): 740-744, 748. [13] WANG PP, YANG Z, LIU DL, et al.Effects of Quercetin on Mitochondrial Energy Metabolism Function after Myocardial Ischemia[J]. China Pharmacy(中国药房), 2024, 35(4): 401-406. [14] CHEN J, YUAN QY, LIU B.Effects of Danshensu on Myocardial Mitochondrial Function in Diabetes Cardiomyopathy Rats Based on PPARγ/PGC-1α Pathway[J]. Traditional Chinese Drug Research and Clinical Pharmacology(中药新药与临床药理), 2024, 35(9): 1329-1336. [15] WANG MN, XU SQ, QIN YM, et al.Action Mechanism of Zhenwu Decoction on Regulating Mitochondrial Energy Metabolism and Improving Myocardial Cell Damage in Chronic Heart Failure Based on the PPARα/ACSL1 Signaling Pathway[J]. Journal of Basic Chinese Medicine(中国中医基础医学杂志), 2025, 31(5): 812-818. [16] SU DD, JIN QR, ZHAO M, et al.Shenlan Granules Ameliorate Doxorubicin-Induced Cardiotoxicity through AMPK/PGC-1α/NRF1-Mediated Mitochondrial Protection[J]. Pharmacology and Clinics of Chinese Materia Medica(中药药理与临床), 2025, 41(9): 2-9. [17] HU MZ, LI XL, JIN JY, et al.Effects of Danshen Decoction Pretreatment on Cardiac Hemodynamics and Mitochondrial Energy Metabolism in Rats with Myocardial Ischemia Reperfusion Injury[J]. Chinese Traditional Patent Medicine(中成药), 2022, 44(7): 2119-2125. [18] ZHAI XQ, ZHU PC, WANG XF, et al.Effect of Qihong Capsule on Myocardial Mitochondrial Energy Metabolism and AKT/AMPK-mTOR Signaling Pathway in Rats with Ischemic Heart Failure[J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease(中西医结合心脑血管病杂志), 2024, 22(12): 2150-2158. [19] ZHANG XT.To Explore the Effect of Huoxue Wentong Formula on the Inflammatory Microenvironment of Ischemic Myocardium by Regulating Mitochondrial Function via the Sirt1/PGC1-α/VDAC1 Axis[D]. Beijing: China Academy of Chinese Medical Sciences, 2023. [20] LI ZN.Fuyang Qiangxin Decoction Improves Mitochondrial Energy Metabolism Mechanism of Heart Failure after Myocardial Infarction[D]. Beijing: China Academy of Chinese Medical Sciences, 2023. [21] GAO H, YANG ZQ, GAO F, et al.Effects of Shengxian Decoction on Cardiac Function and Myocardial Mitochondrial Energy Metabolism in Chronic Heart Failure Rats[J]. Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2025, 45(5): 593-602. [22] YANG J, LIU XY, SUN QH, et al.Alleviation of Resveratrol on the Mouse Cardiac Myocytes Apoptosis Induced by Thermal Stimulation via Regulating Mitochondrial-Mediated Signaling Pathway[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2023, 38(9): 4352-4357. [23] HE HB, WU M, XU J, et al.Mechanism of Vanillic Acid against Isoproterenol-Induced Cardiac Fibrosis in Mice Based on Drp1/HK1/NLRP3 and Mitochondrial Apoptosis Signaling Pathways[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2025, 50(8): 2193-2208. [24] HU T.Notoginsenoside R1 Inhibits Mitochondrial-Dependent Apoptosis by Regulating PI3K/Akt Pathway to Reduce Myocardial Ischemia-Reperfusion Injury[D]. Shanghai: Shanghai University of Traditional Chinese Medicine, 2020. [25] FAN ZJ, XIE LD, CUI J, et al.APS Post-Treatment Protects against Myocardial Ischemia/Reperfusion Injury by Inhibiting Mitochondrial Damage-Mediated Apoptosis[J]. Liaoning Journal of Traditional Chinese Medicine(辽宁中医杂志), 2018, 45(7): 1357-1360. [26] SUN X, ZHAO YF, MA JZ, et al.Mechanism of Danshen and Honghua Mediating Mitochondrial Apoptosis to Improve Myocardial Ischemia-Reperfusion Injury[J]. Progress of Anatomical Sciences(解剖科学进展), 2025, 31(4): 527-530, 534. [27] WEN Y, LI O, HU KJ, et al.Mechanism of Red Ginseng, Astragalus Membranaceus and Their Compatibility on Heart Failure in Rats via Mitochondrial Apoptosis Pathway[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine(现代中西医结合杂志), 2025, 34(6): 731-738. [28] LIU MN, MAO LS, LI ZY, et al.Study on Mechanism of Danshenyin Decoction in Improving Hypoxic/Reoxygenated Cardiomyocyte Injury by Regulating Mitochondrial mPTP Opening[J]. Journal of Chinese Medicinal Materials(中药材), 2024, 47(12): 3108-3113. [29] XIANG M.Research on the Mechanism of JPYX Prescription Improving Mitochondrial Damage in Rats with Heart Failure Following Myocardial Infarction[D]. Beijing: China Academy of Chinese Medical Sciences, 2023. [30] SONG YY, CUI L, HE YF, et al.Effect of Shenfu Yixin Granules on Mitochondrial Dynamics in Rats with Heart Failure after Myocardial Infarction[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2024, 30(11): 87-94. [31] DONG X, CHEN ZX, JIANG JL, et al.Effect and Mechanism of Nuanxinkang on Cardiac Function in Mice with Heart Failure Based on Mitochondrial Dynamics[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2022, 37(6): 3538-3542. [32] XIN GJ, CHEN YY, LIU ZX, et al.Shuangshen Ningxin Capsules Regulates Mitochondrial Fission and Fusion to Alleviate Myocardial Ischemia-Reperfusion Injury in Rats[J]. Chinese Journal of Experi-mental Traditional Medical Formulae(中国实验方剂学杂志), 2024, 30(7): 87-94. [33] MA L, LIU ZC, GAO SW, et al.Qishen Yiqi Dripping Pills Regulate Mitochondrial Fusion through Sirt1/Mfn1 Pathway and Play a Protective Role in Cardiac Function after Myocardial Infarction[J]. Journal of Emergency in Traditional Chinese Medicine(中国中医急症), 2022, 31(4): 568-572. [34] XIE J, GAO B, LIANG SS, et al.Improvement Effects of Pachymic Acid on Myocardial Injury in Coronary Heart Disease Rats by Regula- ting Mitochondrial Autophagy Mediated by the PINK1/Parkin Signaling Pathway[J]. China Pharmacy(中国药房), 2025, 36(18): 2267-2272. [35] ZHANG DW, ZHAO HY, LI QS, et al.Effect of Astragaloside IV and Ginsenoside Rg1 on Autophagy of Myocardial Tissue Injury Induced by Ischemia-Reperfusion Injury in Hyperlipidemic Mice[J]. Chinese Archives of Traditional Chinese Medicine(中华中医药学刊), 2020, 38(3): 60-64. [36] SU C, LIU Y, CHEN C, et al.Regulatory Effect of Xuefu Zhuyu Decoction on Mitochondrial Autophagy in Coronary Heart Disease Rats with Blood Stasis Syndrome via PINK1/Parkin Signaling Pathway[J]. Traditional Chinese Drug Research and Clinical Pharmacology(中药新药与临床药理), 2025, 36(10): 1629-1635. [37] FAN XY, WEI XQ, CHAI WJ, et al.Mechanism of Jiming Powder in Improving Mitophagy for Treatment of Myocardial Infarction Based on PINK1-Parkin Pathway[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2025, 50(12): 3346-3355. [38] LIAO JH, WANG X, WANG XL, et al.Study on the Effect of Zhenwu Tang on PINK1/Parkin Mediated Mitochondrial Autophagy in Rats with Chronic Heart Failure[J]. Journal of Basic Chinese Medicine(中国中医基础医学杂志), 2025, 31(1): 43-48. [39] LI XJ, XIN GJ, CHEN YY, et al.Ginsenoside Re Regulates Mitochondrial Biogenesis through Nrf2/HO-1/PGC-1α Pathway to Reduce Hypoxia/Reoxygenation Injury in H9c2 Cells[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2024, 49(4): 1064-1072. [40] NI YJ, BAI HY, ZHU WJ, et al.Echinacoside Promotes Mitochondrial Biosynthesis and Inhibition of Myocardial Apoptosis by Up-Regulating the PGC-1/NFR Signaling Pathway[J]. Journal of Xi’an Jiaotong University (Medical Sciences)(西安交通大学学报医学版), 2022, 43(4): 607-611. [41] TAN YY, WANG H, WANG YB, et al.Effect of Gualou Xiebai Banxiatang on Mitochondrial Dysfunction and AMPK/PGC-1α Signaling Pathway in Rats with Ischemic Myocardial Injury[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2023, 29(1): 9-17. [42] WANG JY, DONG X, ZHUANG HW, et al.Mechanism of Qishen Granules on Preventing and Treating Ventricular Remodeling in Heart Failure by Regulating Mitochondrial Homeostasis Mediated by SIRT1/PGC-1α/FNDC5 Pathway[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2023, 38(5): 2292-2298. |
| [1] | NI Haoyu, ZHOU Lei, WANG Ningning, YANG Xingxin, ZHOU Wei, SHEN Pan, GAO Yue. Research Advancements in Applications of Single-Cell Transcriptome Sequencing Technology in Mechanism Elucidation of Pharmacodynamics and Toxicity of Traditional Chinese Medicine [J]. Chinese Journal of Pharmacovigilance, 2025, 22(9): 975-982. |
| [2] | WANG Xuezhen, SUN Yang, SUN Qi, ZHAO Nan, WANG Lin, YUE Jiayin, MENG Fanhao. Research Progress in Metabolomics of Depression and Regulatory Mechanisms of Traditional Chinese Medicine [J]. Chinese Journal of Pharmacovigilance, 2025, 22(9): 1061-1067. |
| [3] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [4] | LIU Lianlian, YU Huiyong, WANG Mingzhe, GUO Shanshan, LI Lei, GAO Yue, WEI Shixiang, KE Yinze, WANG Chengxiang. TCM Medications for Pulmonary Nodules Based on Traditional Chinese Medicine Inheritance Assistance System [J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 513-516. |
| [5] | LI Shuran, XIE Rui, ZHAO Ronghua, BAO Lei, GENG Zihan, SUN Qiyue, CUI Xiaolan, GUO Shanshan, SUN Jing. Research Progress in the Pathogenesis and Medications of Trigeminal Neuralgia [J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 596-600. |
| [6] | GUO Dongqi, WANG Hao, BAI Xin, BAI Jianqi, SU Hongmei, ZHANG Jingru, GUO Xiaofei, ZHAO Xiaoqi, WANG Min, WANG Yuan, ZHANG Ping. Identification of Druggable Targets for Intervertebral Disc Degeneration Based on Multi-Omics Data-Driven Mendelian Randomization and Prediction of Traditional Chinese Medicine Interventions [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 241-248. |
| [7] | BAI Xin, WANG Min, WANG Yuan, BAI Jianqi, SU Shuang, LIU Guanghui, GUO Xiaofei, KANG Jiaqi, GUO Dongqi, ZHANG Yimeng, WANG Hao, ZHAO Xiaoqi, ZHANG Ping. Traditional Chinese Medicine Used in the Treatment of Gout Complicated with Osteoarthritis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 258-262. |
| [8] | JIA Zhichao, HU Siyuan, LI Ruiben, XU Yaqian. Safety of Children’s Traditional Chinese Medicine Decoction Pieces in Clinical Application and Children’s Drug Development [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 324-328. |
| [9] | LIANG Xiao, LI Li, XU Xiaolong, BAI Yinglu, YANG Yumei, ZHU Yong, LIU Qingquan. Advancements in Treatment of Brucellosis with Traditional Chinese Medicine [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 231-234. |
| [10] | BAI Xue, LIU Jianxun, LI Xueli. Mechanisms of Shuangshen Ningxin Capsule against Myocardial Infarction in Mice Based on Transcriptomics [J]. Chinese Journal of Pharmacovigilance, 2025, 22(12): 1334-1339. |
| [11] | YANG Chuang, ZHOU Ying, ZHU Xiang, LI Na, QUAN Mingxia, WAN Jiangju, SHEN Hong, CHEN Jie. Clinical Profiles and Risk Factors of 400 Cases of Drug-Induced Liver Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(12): 1404-1409. |
| [12] | ZHAO Ziyi, LU Chengjin, ZHANG Xiaomeng, HUANG Huaijuan, ZHANG Bing. Bleeding Risk and Interactions of Warfarin Combined with Traditional Chinese Medicine [J]. Chinese Journal of Pharmacovigilance, 2025, 22(11): 1217-1222. |
| [13] | SHAO Bo, GUO Xiaoxin. Review of pharmacovigilance of traditional Chinese medicine [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 741-745. |
| [14] | LIU Yang, FAN Zheng, WANG Honglei, YANG Ying, GUO Qi, CHANG Xinyu, HAN Lijuan, LI Wenzhe, WU Jiankun. Therapeutic effect of Jingzhui Kangfu pills against osteoarthritis induced by proteoglycan in mice [J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 651-654. |
| [15] | LI Yao, CHEN Yuxin, GAO Haiyun, LI Hui, LIU Tianrui, YUAN Yuan. Analysis of prescription rules for Omphalia lapidescens based on the Dictionary of Chinese Traditional Medicine Prescriptions [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 553-558. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||